New Zealand markets close in 2 hours 18 minutes

ABVC BioPharma, Inc. (ABVC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0600-0.0200 (-1.85%)
At close: 04:00PM EDT
1.0500 -0.01 (-0.94%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
342.996
152.43
969.783
355.797
483.045
Cost of revenue
23.806
302.037
286.415
5.086
18.716
Gross profit
319.19
-149.607
683.368
350.711
464.329
Operating expenses
Research development
1,458
1,063
2,693
1,004
549.658
Selling general and administrative
17,290
7,004
13,104
11,053
8,420
Total operating expenses
18,644
8,067
15,798
11,696
8,970
Operating income or loss
-18,324
-8,217
-15,114
-11,345
-8,506
Interest expense
135.14
2,493
293.968
227.21
405.032
Total other income/expenses net
494.966
-129.914
-294.033
318.257
-1,974
Income before tax
-17,867
-10,654
-15,515
-11,211
-10,814
Income tax expense
846.183
256.006
797.778
825.024
-220.352
Income from continuing operations
-18,713
-10,910
-16,312
-12,036
-10,594
Net income
-19,492
-10,516
-16,423
-12,839
-9,791
Net income available to common shareholders
-19,492
-10,516
-16,423
-12,839
-9,791
Basic EPS
-3.57
-
-5.19
-5.10
-5.00
Diluted EPS
-3.57
-
-5.19
-5.10
-5.00
Basic average shares
3,493
-
3,166
2,505
1,972
Diluted average shares
3,493
-
3,166
2,505
1,972